BioWorld Asia

March 23, 2005

Plethora Makes Comeback With £10M Flotation On AIM

LONDON - Plethora Solutions Holdings, a specialist in sexual dysfunction and urology products, raised £10 million (US$19 million) in a flotation on the Alternative Investment Market in London. (BioWorld International) Read More

European Leaders Say They Mean It This Time: Biotech Help Coming

Analysis Of Genes For X-Linked Diseases Will Stimulate Research

TopoTarget Raises EUR15M In Series C For Cancer Pipeline

Arpida Moving Iclaprim Into Pivotal Trials For Infections

Biovitrum Acquires Cambridge Firm In First Of Expected Deals

Oxford Genome Establishes Biomarker Deal With Bayer

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for July 14, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for July 14, 2025.

Circode applies circRNA to heart disease drug R&D, in vivo CAR T

BioWorld

Shanghai Circode Biomed Co. Ltd. is set to begin clinical trials of HM-2002, a circular RNA (circRNA)-based drug for ischemic heart disease, having gained IND...

BD’s biosciences & diagnostics unit in $17.5B merger with Waters

BioWorld MedTech

Three months earlier than an expected update on a deal, Becton, Dickinson and Co. reported its biosciences and diagnostic solutions business will combine with...

Ultragenyx hit again, this time with a CRL in rare disease

BioWorld

Manufacturing issues are the latest problem for Ultragenyx Pharmaceutical Inc. to solve after last week’s disappointment in a phase III study to treat brittle...